Zhanwei Wang
Impact in
- Molecular Medicine top 1%
- Antibiotic Resistance in Bacteria
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Epigenetics and DNA Methylation 7
- RNA modifications and cancer 7
- DNA Repair Mechanisms 4
-
- Antibiotic Resistance in Bacteria 12
- Co-authors
- Yuanyuan Fu (13 shared papers)Zhibin Hu (4 shared papers)Hui Wang (19 shared papers)Hongbing Shen (3 shared papers)Herbert Yu (16 shared papers)Xinru Wang (2 shared papers)Xiaoyi Zhou (2 shared papers)Ruifen Miao (1 shared paper)
- Journals
- Breast Cancer Research and Treatment (12 papers)Infection and Drug Resistance (5 papers)Scientific Reports (3 papers)Frontiers in Microbiology (2 papers)Diagnostic Microbiology and Infectious Disease (2 papers)
- Partner nations
- ChinaUnited StatesItaly
In The Last Decade
Zhanwei Wang
87 papers receiving 2.2k citations
Zhanwei Wang's Hit Papers
Peers
Comparison fields: 5 of 116
- Molecular Medicine 331
- Cancer Research 584
- Applied Microbiology and Biotechnology 60
- Infectious Diseases 340
- Endocrinology 72
Countries citing papers authored by Zhanwei Wang
This map shows the geographic impact of Zhanwei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhanwei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhanwei Wang more than expected).
Fields of papers citing papers by Zhanwei Wang
This network shows the impact of papers produced by Zhanwei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhanwei Wang. The network helps show where Zhanwei Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhanwei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 87 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 330 | |
| 2 | Risk Factors Associated With Clinical Outcomes in 323 Coronavirus Disease 2019 (COVID-19) Hospitalized Patients in Wuhan, China Hit paper breakdown → | 2020 | 298 |
| 3 | 2018 | 90 | |
| 4 | 2015 | 82 | |
| 5 | 2013 | 79 | |
| 6 | 2012 | 59 | |
| 7 | 2018 | 57 | |
| 8 | 2013 | 56 | |
| 9 | 2015 | 55 | |
| 10 | 2013 | 55 | |
| 11 | 2015 | 54 | |
| 12 | 2016 | 52 | |
| 13 | 2020 | 45 | |
| 14 | 2019 | 41 | |
| 15 | 2009 | 38 | |
| 16 | 2008 | 35 | |
| 17 | 2020 | 34 | |
| 18 | 2010 | 33 | |
| 19 | 2010 | 30 | |
| 20 | 2013 | 29 |
About Zhanwei Wang
Zhanwei Wang is a scholar working on Molecular Biology, Molecular Medicine, Cancer Research, Oncology and Epidemiology, having authored 87 papers that have together received 2.2k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (12 papers), Cancer-related molecular mechanisms research (10 papers), Pneumonia and Respiratory Infections (7 papers), Epigenetics and DNA Methylation (7 papers), RNA modifications and cancer (7 papers), Antimicrobial Resistance in Staphylococcus (5 papers), DNA Repair Mechanisms (4 papers) and Antibiotic Use and Resistance (4 papers). The work is most often cited by research in Molecular Medicine (331 citations), Cancer Research (584 citations), Applied Microbiology and Biotechnology (60 citations), Infectious Diseases (340 citations) and Endocrinology (72 citations). Zhanwei Wang has collaborated with scholars based in China, United States and Italy. Frequent co-authors include Yuanyuan Fu, Zhibin Hu, Hui Wang, Hongbing Shen, Herbert Yu, Xinru Wang, Xiaoyi Zhou, Ruifen Miao, Jiaping Chen and Tian Tian. Their work appears in journals such as Breast Cancer Research and Treatment, Infection and Drug Resistance, Scientific Reports, Frontiers in Microbiology and Diagnostic Microbiology and Infectious Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.